搜索医生

Andrew J. Barkmeier, M.D.

  1. Ophthalmologist
预约门诊

出版物

  1. Kim BM, Wang KY, Xu TT, Hooshmand SJ, Toups GN, Millman MP, Steinkraus LW, Tooley AA, Barkmeier AJ, Chen JJ. Outcomes of Hyperbaric Oxygen Treatment for Central Retinal Artery Occlusion: A Single Center Experience. Am J Ophthalmol. 2025 Jan; 269:393-401 Epub 2024 Oct 04
    View PubMed
  2. Bai P, Barkmeier AJ, Hodge DO, Mohney BG. Incidence and sex differences of diabetes among youth: a 50-year population-based cohort study. Acta Diabetol. 2024 Dec; 61 (12):1511-1516 Epub 2024 June 07
    View PubMed
  3. Bou Said R, Barkmeier AJ. Bilateral Perifoveal Atrophy in a 46-Year-Old Woman. JAMA Ophthalmol. 2024 Nov 7 Epub 2024 Nov 07
    View PubMed
  4. Barkmeier AJ, Herrin J, Swarna KS, Deng Y, Polley EC, Umpierrez GE, Galindo RJ, Ross JS, Mickelson MM, McCoy RG. Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy. Ophthalmol Retina. 2024 Oct; 8 (10):943-952 Epub 2024 May 11
    View PubMed
  5. Mandviwala MM, Adams MK, Barkmeier AJ. The forbidden touch: mechanical clearing of gas-induced crystalline lens feathering during vitrectomy surgery. Int J Retina Vitreous. 2024 Jul 22; 10 (1):49 Epub 2024 July 22
    View PubMed
  6. Tailor PD, Dalvin LA, Chen JJ, Iezzi R, Olsen TW, Scruggs BA, Barkmeier AJ, Bakri SJ, Ryan EH, Tang PH, Parke DW 3rd, Belin PJ, Sridhar J, Xu D, Kuriyan AE, Yonekawa Y, Starr MR. A Comparative Study of Responses to Retina Questions from Either Experts, Expert-Edited Large Language Models, or Expert-Edited Large Language Models Alone. Ophthalmol Sci. 2024 Jul-Aug; 4 (4):100485 Epub 2024 Feb 06
    View PubMed
  7. McDonald JA, Barkmeier A, Scruggs B. Focal choroidal excavation (FCE)-related choroidal neovascular membrane (CNV) in a child Retina Cases & Brief Reports. 2024.
  8. Fairbanks AM, Salomao DR, Barkmeier AJ. Metastatic papillary renal cell carcinoma to the retina and vitreous. Am J Ophthalmol Case Rep. 2024 Jun; 34:102035 Epub 2024 Feb 29
    View PubMed
  9. Tailor PD, Xu TT, Fortes BH, Iezzi R, Olsen TW, Starr MR, Bakri SJ, Scruggs BA, Barkmeier AJ, Patel SV, Baratz KH, Bernhisel AA, Wagner LH, Tooley AA, Roddy GW, Sit AJ, Wu KY, Bothun ED, Mansukhani SA, Mohney BG, Chen JJ, Brodsky MC, Tajfirouz DA, Chodnicki KD, Smith WM, Dalvin LA. Appropriateness of Ophthalmology Recommendations From an Online Chat-Based Artificial Intelligence Model. Mayo Clin Proc Digit Health. 2024 Mar; 2(1):119-128. Epub 2024 Feb 15.
    View PubMed
  10. Tooley AA, Law J, Lelli GJ, Sun G, Godfrey KJ, Tran AQ, Kim E, Solomon JM, Chen JJ, Khan AR, Wayman L, Olson JH, Lee MS, Harrison AR, Espinoza GM, Davitt BV, Tao J, Hodge DO, Barkmeier AJ. Predictors of Ophthalmology Resident Performance From Medical Student Application Materials. J Surg Educ. 2024 Jan; 81 (1):151-160 Epub 2023 Nov 30
    View PubMed
  11. Lyons LJ, Kazemi A, Bakri SJ, Barkmeier AJ, Iezzi R, Olsen TW, Hodge DO, Sit AJ. The Effect of Scleral Buckle Surgery on Tonographic Outflow Facility, Positional Intraocular Pressure, and Ocular Biomechanics. Ophthalmol Glaucoma. 2024 Jan-Feb; 7(1):1-7. Epub 2023 Jul 22.
    View PubMed
  12. Fortes BH, Fairbanks AM, Nirmalan AA, Hodge DO, Ferenchak K, Barkmeier AJ. Diurnal variation of optical coherence tomography-based macular fluid in exudative age-related macular degeneration. Int J Retina Vitreous. 2023 Sep 25; 9 (1):57 Epub 2023 Sept 25
    View PubMed
  13. Sanfilippo CJ, Javaheri M, Handler S, Berry JL, Cobrinik D, Deardorff MA, Sun M, Schmidt RJ, Barkmeier AJ, Nagiel A. Benign Lobular Inner Nuclear Layer Proliferations of the Retina Associated with Congenital Hypertrophy of the Retinal Pigment Epithelium. Ophthalmology. 2023 Mar; 130 (3):265-273 Epub 2022 Oct 18
    View PubMed
  14. Mehra AA, Softing A, Guner MK, Hodge DO, Barkmeier AJ. Diabetic Retinopathy Telemedicine Outcomes With Artificial Intelligence-Based Image Analysis, Reflex Dilation, and Image Overread. Am J Ophthalmol. 2022 Dec; 244:125-132 Epub 2022 Aug 13
    View PubMed
  15. Fortes BH, Astafurov KV, Hodge DO, Smith WM, Barkmeier AJ, Olsen TW, Iezzi R, Bakri SJ. EFFECT OF PHYSICIAN FACE MASK USE ON POSTINJECTION ENDOPHTHALMITIS. Retina. 2022 Nov 1; 42 (11):2120-2127
    View PubMed
  16. Willett K, Barkmeier A. Layperson Minimal-Resource Smartphone Retinal Photography. Ophthalmol Retina. 2022 Oct; 6 (10):885 Epub 2022 Aug 07
    View PubMed
  17. Shen BY, Salman AR, Shah SM, Hassan MB, Alniemi S, Goyal DG, Barkmeier AJ. Clinical Outcomes Following Implementation of a Formalized "Flashes and Floaters" Emergency Department Triage Protocol. Am J Ophthalmol. 2022 Oct; 242:125-130 Epub 2022 June 21
    View PubMed
  18. Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK, DRCR Retina Network. Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema. N Engl J Med. 2022 Aug 25; 387 (8):692-703 Epub 2022 July 14
    View PubMed
  19. Dabit JY, Hocaoglu M, Moder KG, Barkmeier AJ, Smith WM, O'Byrne TJ, Crowson CS, Duarte-Garcia A. Risk of hydroxychloroquine retinopathy in the community. Rheumatology (Oxford). 2022 Aug 3; 61 (8):3172-3179
    View PubMed
  20. Astafurov KV, Barkmeier AJ. Angiographic dark choroid in systemic non-hereditary amyloidosis. Am J Ophthalmol Case Rep. 2022 Mar; 25:101334 Epub 2022 Feb 08
    View PubMed
  21. Bai P, Barkmeier AJ, Hodge DO, Mohney BG. Ocular Sequelae in a Population-Based Cohort of Youth Diagnosed With Diabetes During a 50-Year Period. JAMA Ophthalmol 2022 Jan 1; 140 (1):51-57
    View PubMed
  22. Fortes BH, Dalvin LA, Hogan WJ, Patnaik MM, Choong GM, Salomao DR, Barkmeier AJ, Bhatti MT. Isolated T-cell acute lymphoblastic leukemic optic disc infiltration. Am J Hematol. 2021 Dec 1; 96 (12):1717-1718 Epub 2021 Sept 30
    View PubMed
  23. Starr MR, Mahr MA, Smith WM, Iezzi R, Barkmeier AJ, Bakri SJ. Outcomes of Patients With Active Diabetic Macular Edema at the Time of Cataract Surgery Managed With Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Am J Ophthalmol. 2021 Sep; 229:194-199. Epub 2021 Apr 20.
    View PubMed
  24. Grosinger AJ, Nicholson BP, Shah SM, Pulido JS, Barkmeier AJ, Iezzi R, Bakri SJ. Time to Unplanned Return to the Operating Room and Associated Risk Factors in Patients With Surgical Retinal Detachment Repair. Am J Ophthalmol. 2021 Sep; 229:18-25. Epub 2021 Feb 21.
    View PubMed
  25. Tooley AA, Hur MJ, Lachman N, Barkmeier AJ. Cadaveric simulation improves ophthalmology resident confidence and preparedness for emergent ophthalmic procedures. Can J Ophthalmol 2021 Aug; 56 (4):e133-e135 Epub 2021 Mar 16
    View PubMed
  26. Shah SM, Barkmeier AJ, Dalvin LA, Tooley AA. Applicant Perceptions Regarding the 2020 to 2021 Virtual Ophthalmology Residency Interview and Match Season. J Acad Ophthalmol (2017). 2021 Jul; 13 (2):e144-e150 Epub 2021 Nov 10
    View PubMed
  27. Astafurov KV, Bakri SJ, Barkmeier AJ. Ocular Toxicity Associated With Pentosan Polysulfate Sodium. Mayo Clin Proc 2021 Jun; 96 (6):1682-1684
    View PubMed
  28. Chan CK, Mein CE, Glassman AR, Beaulieu WT, Calhoun CT, Jaffe GJ, Jampol LM, MacCumber MW, Maguire MG, Maturi RK, Salehi-Had H, Rofagha S, Sun JK, Martin DF, DRCR Retina Network. Pneumatic Vitreolysis with C3F8 for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH. Ophthalmology. 2021 May 11 [Epub ahead of print]
    View PubMed
  29. Hainsworth DP, Gao X, Bebu I, Das A, Olmos de Koo L, Barkmeier AJ, Tamborlane W, Lachin JM, Aiello LP, Diabetes Control and Complications Trial and Follow-up Epidemiology of Diabetes Interventions and Complications Research Group. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Ophthalmology. 2021 Apr; 128 (4):554-560 Epub 2020 Sept 14
    View PubMed
  30. Hutton DW, Glassman AR, Stein JD, Bressler NM, Sun JK, DRCR Retina Network. Costs of Managing Diabetic Macular Edema with Good Visual Acuity with Aflibercept, Laser or Observation: DRCR Retina Network Protocol V. Am J Ophthalmol. 2021 Mar 10 [Epub ahead of print]
    View PubMed
  31. Beaulieu WT, Glassman AR, Baker CW, Maguire MG, Johnson CA, Melia M, Sun JK, DRCR Retina Network. Effect of Initial Aflibercept, Laser, or Observation on Low-Contrast Visual Acuity in Eyes With Diabetic Macular Edema and Good Vision: Ancillary Study Within a Randomized Clinical Trial. Transl Vis Sci Technol. 2021 Mar 1; 10 (3):3
    View PubMed
  32. Maloney MH, Payne SR, Herrin J, Sangaralingham LR, Shah ND, Barkmeier AJ. Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice. Ophthalmology. 2021 Mar; 128 (3):417-424 Epub 2020 Aug 08
    View PubMed
  33. Barkmeier AJ. Toward Optimal Screening for Diabetic Retinopathy: Balancing Precision and Pragmatism. Mayo Clin Proc 2021 Feb; 96 (2):282-284
    View PubMed
  34. Shah SM, Barkmeier AJ, Bakri SJ. Recurrent panuveitis after initial treatment of endophthalmitis secondary to intravitreal anti-vascular endothelial growth factor. Can J Ophthalmol 2020 Dec; 55 (6):e195-e197 Epub 2020 Aug 20
    View PubMed
  35. Platt SM, Barkmeier AJ. Endoscope-assisted scleral buckle procedure. Int J Retina Vitreous. 2020 Nov 11; 6 (1):52
    View PubMed
  36. Starr MR, Mahr MA, Iezzi R, Barkmeier AJ, Bakri SJ. Visual and Anatomic Outcomes following Cataract Surgery in Patients with Pre-operative Macular Edema Due to Retinal Vein Occlusions Managed with Intravitreal anti-VEGF. Semin Ophthalmol. 2020 May 18; 35(4):205-209. Epub 2020 Jul 28.
    View PubMed
  37. Glassman AR, Baker CW, Beaulieu WT, Bressler NM, Punjabi OS, Stockdale CR, Wykoff CC, Jampol LM, Sun JK, DRCR Retina Network. Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2020 Apr 1; 138 (4):341-349
    View PubMed
  38. Starr MR, Barkmeier AJ, Engman SJ, Kitzmann A, Bakri SJ. Telemedicine in the Management of Exudative Age-Related Macular Degeneration within an Integrated health care System. Am J Ophthalmol. 2019 Dec; 208:206-210. Epub 2019 Mar 21.
    View PubMed
  39. Bressler NM, Odia I, Maguire M, Glassman AR, Jampol LM, MacCumber MW, Shah C, Rosberger D, Sun JK, DRCR Retina Network. Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab: A Post Hoc Analysis of the Protocol T Randomized Clinical Trial. JAMA Ophthalmol. 2019 Sep 1; 137 (9):977-985
    View PubMed
  40. Maloney MH, Schilz SR, Herrin J, Sangaralingham LR, Shah ND, Barkmeier AJ. Risk of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice. Ophthalmology. 2019 Jul; 126 (7):1007-1015 Epub 2018 Oct 04
    View PubMed
  41. Singman EL, Boland MV, Tian J, Green LK, Srikumaran D. Supervision and autonomy of ophthalmology residents in the outpatient clinic in the United States II: a survey of senior residents. BMC Med Educ. 2019 Jun 13; 19 (1):202 Epub 2019 June 13
    View PubMed
  42. Baker CW, Glassman AR, Beaulieu WT, Antoszyk AN, Browning DJ, Chalam KV, Grover S, Jampol LM, Jhaveri CD, Melia M, Stockdale CR, Martin DF, Sun JK. Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial. JAMA. 2019 May 21; 321 (19):1880-1894
    View PubMed
  43. Hainsworth DP, Bebu I, Aiello LP, Sivitz W, Gubitosi-Klug R, Malone J, White NH, Danis R, Wallia A, Gao X, Barkmeier AJ, Das A, Patel S, Gardner TW, Lachin JM, Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes Care. 2019 May; 42 (5):875-882 Epub 2019 Mar 04
    View PubMed
  44. Mansukhani SA, Barkmeier AJ, Bakri SJ, Iezzi R, Pulido JS, Khanna CL, Bennett JR, Hodge DO, Sit AJ. The Risk of Primary Open-Angle Glaucoma Following Vitreoretinal Surgery-A Population-based Study. Am J Ophthalmol 2019 Jan 22 [Epub ahead of print]
    View PubMed
  45. Mansukhani SA, Barkmeier AJ, Bakri SJ, Iezzi R, Pulido JS, Khanna CL, Bennett JR, Hodge DO, Sit AJ. The Risk of Primary Open-Angle Glaucoma Following Vitreoretinal Surgery-A Population-based Study. Am J Ophthalmol. 2018 Sep; 193:143-155 Epub 2018 June 27
    View PubMed
  46. Starr MR, Mahr MA, Barkmeier AJ, Iezzi R, Smith WM, Bakri SJ. Outcomes of Cataract Surgery in Patients With Exudative Age-related Macular Degeneration and Macular Fluid. Am J Ophthalmol. 2018 Aug; 192:91-97. Epub 2018 May 23.
    View PubMed
  47. Jampol LM, Glassman AR, Liu D, Aiello LP, Bressler NM, Duh EJ, Quaggin S, Wells JA, Wykoff CC. Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema. Ophthalmology. 2018 Jul; 125 (7):1054-1063 Epub 2018 Mar 07
    View PubMed
  48. Dalvin LA, Salomão DR, Iezzi R, Barkmeier AJ. Subconjunctival Exposure to Carbopol Causes Chronic Histiocytic Inflammatory Response in Rabbits. Transl Vis Sci Technol. 2018 May; 7(3):9. Epub 2018 May 31.
    View PubMed
  49. Bressler NM, Beaulieu WT, Glassman AR, Blinder KJ, Bressler SB, Jampol LM, Melia M, Wells JA 3rd, Diabetic Retinopathy Clinical Research Network. Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2018 Mar 1; 136 (3):257-269
    View PubMed
  50. Glassman AR, Liu D, Jampol LM, Sun JK, Diabetic Retinopathy Clinical Research Network . Changes in Blood Pressure and Urine Albumin-Creatinine Ratio in a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema. Invest Ophthalmol Vis Sci. 2018 Mar 1; 59 (3):1199-1205
    View PubMed
  51. Veverka KK, Hatt SR, Leske DA, Brown WL, Barkmeier AJ, Lezzi R Jr, Iezzi R Jr, Holmes JM. Prevalence and Associations of Central-Peripheral Rivalry-Type Diplopia in Patients With Epiretinal Membrane. JAMA Ophthalmol. 2017 Dec 1; 135 (12):1303-1309
    View PubMed
  52. Atchison EA, Omar AF, Iezzi R, Barkmeier AJ, Bakri SJ. OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC. Retina. 2017 Jul; 37(7):1371-1376.
    View PubMed
  53. Javey G, Rigi M, Barkmeier AJ, Heffez JL, Carvounis PE. SCLEROTOMY LEAKAGE IN TRANSCONJUNCTIVAL SMALL-GAUGE PARS PLANA VITRECTOMY: Effect of Removing the Cannula Over the Light Pipe. Retina. 2017 Jun; 37 (6):1079-1083
    View PubMed
  54. Parikh R, Ross JS, Sangaralingham LR, Adelman RA, Shah ND, Barkmeier AJ. Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients. Ophthalmology. 2017 Mar; 124(3):352-358. Epub 2016 Nov 24.
    View PubMed
  55. Barkmeier AJ, Salomao DM, Baratz KH. MANAGEMENT OF MYCOBACTERIUM CHELONAE ENDOPHTHALMITIS WITH COMPLETE SURGICAL DEBRIDEMENT. Retina. 2016 Dec; 36 (12):2440-2442
    View PubMed
  56. Jampol LM, Glassman AR, Bressler NM, Wells JA, Ayala AR, Diabetic Retinopathy Clinical Research Network. Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial. JAMA Ophthalmol. 2016 Dec 01; 134: (12).
    View PubMed
  57. Dalvin LA, Garcia MD, Salomão DR, Iezzi R, Barkmeier AJ. Necrotizing Subconjunctival Granulomata and Intraoperative Use of Topical GenTeal Gel. Ophthalmology. 2016 Oct; 123(10):2262-3. Epub 2016 Jun 17.
    View PubMed
  58. Ross EL, Hutton DW, Stein JD, Bressler NM, Jampol LM, Glassman AR, Diabetic Retinopathy Clinical Research Network. Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial. JAMA Ophthalmol. 2016 Aug 01; 134: (8)888-96.
    View PubMed
  59. Erie JC, Barkmeier AJ, Hodge DO, Mahr MA. High Variation of Intravitreal Injection Rates and Medicare Anti-Vascular Endothelial Growth Factor Payments per Injection in the United States. Ophthalmology. 2016 Jun; 123 (6):1257-62 Epub 2016 Mar 12
    View PubMed
  60. Roddy GW, Kreuter JD, Koh BD, Barkmeier AJ. Central retinal vein occlusion after plateletpheresis. Transfusion. 2016 Jun; 56 (6):1258
    View PubMed
  61. Wells JA, Glassman AR, Ayala AR, Jampol LM, Bressler NM, Bressler SB, Brucker AJ, Ferris FL, Hampton GR, Jhaveri C, Melia M, Beck RW, Diabetic Retinopathy Clinical Research Network . Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. Ophthalmology.2016 Jun;123:(6):1351-9.
    View PubMed
  62. Maxfield SD, Barkmeier AJ. Exudative Macular Detachment After Viral Illness With Rash. JAMA Ophthalmol. 2016 Mar; 134: (3)335-6.
    View PubMed
  63. Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW, Diabetic Retinopathy Clinical Research Network. Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema. JAMA Ophthalmol. 2016 Feb; 134(2):127-34.
    View PubMed
  64. Atchison E, Barkmeier A. The Role of Systemic Risk Factors in Diabetic Retinopathy. Curr Ophthalmol Rep. 2016; 4 (2):84-89 Epub 2016 Mar 25
    View PubMed
  65. Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW, Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015 Mar 26; 372: (13)1193-203.
    View PubMed
  66. Carvounis PE, Albini TA, Barkmeier AJ, Tsilimbaris M. Advances in retinal therapeutics. J Ophthalmol. 2015; 2015:515193 Epub 2015 Mar 09
    View PubMed
  67. Kapoor KG, Barkmeier AJ, Bakri SJ. Optical coherence tomography in retinal arterial occlusions: case series and review of the literature. Semin Ophthalmol. 2015 Jan; 30(1):74-9. Epub 2013 Sep 27.
    View PubMed
  68. Kapoor KG, Barkmeier AJ. Xanthic Scotoma. JAMA Ophthalmology.2014 Nov;132:(11):1354.
    View PubMed
  69. Kapoor KG, Hodge DO, St Sauver JL, Barkmeier AJ. Oral fluoroquinolones and the incidence of rhegmatogenous retinal detachment and symptomatic retinal breaks: a population-based study. Ophthalmology. 2014 Jun; 121 (6):1269-73 Epub 2014 Jan 28
    View PubMed
  70. Chen GW, Barkmeier AJ. Perioperative management of antithrombotic medications in vitreoretinal surgery. Int Ophthalmol Clin.2014 Spring;54:(2):199-13.
    View PubMed
  71. Nicholson BP, Barkmeier AJ. Bevacizumab and diabetic vitrectomy. Int Ophthalmol Clin. 2014 Spring; 54(2):111-26.
    View PubMed
  72. Grassi MA, Sun W, Gangaputra S, Cleary PA, Hubbard L, Lachin JM, Gao X, Kiss S, Barkmeier AJ, Almony A, Davis M, Klein R, Danis RP, DCCT/EDIC Research Group. Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy. Ophthalmology. 2013 Dec; 120 (12):2580-2586 Epub 2013 July 24
    View PubMed
  73. Kavoussi SC, Shetlar DJ, Barkmeier AJ, Carvounis PE. Invasive conjunctival squamous cell carcinoma presenting with serous retinal detachment. Can J Ophthalmol 2013 Dec; 48 (6):e158-9
    View PubMed
  74. Nathan DM, Bayless M, Cleary P, Genuth S, Gubitosi-Klug R, Lachin JM, Lorenzi G, Zinman B, DCCT/EDIC Research Group. Diabetes control and complications trialepidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes. 2013 Dec; 62: (12)3976-86.
    View PubMed
  75. Kapoor KG, Baratz KH, Barkmeier AJ. Laser photocoagulation of an avulsed persistent pupillary membrane vessel causing recurrent hyphaema. Clin Exp Ophthalmol 2013 Jul; 41 (5):513-5 Epub 2013 Jan 24
    View PubMed
  76. Singh R, Reddy DM, Barkmeier AJ, Holz ER, Ram R, Carvounis PE. Long-term visual outcomes following lens-sparing vitrectomy for retinopathy of prematurity. Br J Ophthalmol. 2012 Nov; 96(11):1395-8. Epub 2012 Aug 24.
    View PubMed
  77. Pulido JS, Barkmeier AJ, Leavitt JA, Lewis RA. Screening for hydroxychloroquine toxicity. Ophthalmology 2012 Jan; 119 (1):207; author reply 207-8
    View PubMed
  78. Barkmeier AJ, Carvounis PE, Holz ER. Long-term observation of exposed scleral exoplant without topical antibiotic prophylaxis. Retinal Cases & Brief Reports.2011 Winter;5:(1):16-17.
    View PubMed
  79. Barkmeier AJ, Kadikoy H, Holz ER, Carvounis PE. Regression of serous macular detachment due to peripheral exudative hemorrhagic chorioretinopathy following intravitreal bevacizumab. Eur J Ophthalmol. 2011 Jul-Aug; 21 (4):506-8
    View PubMed
  80. Barkmeier AJ, Carvounis PE. Retinal pigment epithelial tears and the management of exudative age-related macular degeneration. Semin Ophthalmol. 2011 May; 26(3):94-103.
    View PubMed
  81. Mojumder DK, Concepcion FA, Patel SK, Barkmeier AJ, Carvounis PE, Wilson JH, Holz ER, Wensel TG. Evaluating retinal toxicity of intravitreal caspofungin in the mouse eye. Invest Ophthalmol Vis Sci. 2010 Nov; 51(11):5796-803. Epub 2010 May 26.
    View PubMed
  82. Kadikoy H, Barkmeier A, Peck B, Carvounis PE. Persistent photopsia following course of oral voriconazole. J Ocul Pharmacol Ther. 2010 Aug; 26(4):387-8.
    View PubMed
  83. Ernst BJ, Barkmeier AJ, Akduman L. Optical coherence tomography-based intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. International Ophthalmology.2010 Jun;30:(3):267-70.
    View PubMed
  84. Barkmeier AJ, Feman SS. Frosted branch angiitis secondary to herpes simplex virus infection progressing to acute retinal necrosis. Retinal Cases & Brief Reports.2009 Winter;3:(1):36-7.
    View PubMed
  85. Barkmeier AJ, Akduman L, Ernst BJ, Oz O. Regression of choroidal neovascularization secondary to pathologic myopia after intravitreal injection of bevacizumab. Retina-Vitreus. 2009; 17:222-4.
  86. Barkmeier AJ, Nicholson BP, Akduman L. Effectiveness of laser photocoagulation in clinically significant macular edema with focal vs. diffuse parafoveal thickening on optical coherence tomography Ophthalmic Surg Lasers Imaging.2009 Sept-Oct;40:(5):472-9.
    View PubMed
  87. Barkmeier AJ, Akduman L. Bevacizumab (Avastin) in ocular processes other than choroidal neovascularization. Ocul Immunol Inflamm.2009 Mar-April;17:(2):109-17.
    View PubMed
  88. Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K, Pfister SL, Campbell WB, Hillard CJ. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonyglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol pharmacol.2004 Apr;65:(4):999-1007.
    View PubMed
  89. Rademacher DJ, Kearn CS, Carrier EJ, Patel S, Delgdo MA, Barkmeier AJ, Klck DE, Breese NM, Pfister SL, Nithipatikom K, Campbell WB, Hillard CJ. Production of hydroxyeicosatetraenoic acids and porstaglandins by a novel ratmicroglial cell line. J Neuroimmunol.2004 Apr;149:(1-2):130-41.
    View PubMed
PST-20225865